Interposed Nucleus (Interposed Cerebellar Nucleus) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
::::{.infobox .infobox-celltype} [1]
| Attribute | Value | [2]
|-----------|-------| [3]
| Cell Type Name | Interposed Nucleus (Interposed Cerebellar Nucleus) Neurons | [4]
| Allen Atlas ID | N/A (Cerebellar deep nuclei) | [5]
| Lineage | GABAergic neuron > cerebellar deep nucleus > interposed | [6]
| Marker Genes | GAT-1, GABRA2, HOXA5, AQP4 | [7]
| Brain Regions | Cerebellum, lateral cerebellum near vermis |
| Neurotransmitter | GABA (Purkinje cell target) |
::::
The Interposed Nucleus (also called the Nucleus Interpositus) is the intermediate cerebellar deep nucleus located between the Fastigial Nucleus (medially) and the Dentate Nucleus (laterally). It receives inhibitory GABAergic input from Purkinje cells of the cerebellar hemispheres and is the primary output for the spinocerebellum. The interposed nucleus coordinates limb movement, precision motor tasks, and learned motor patterns.
The Interposed Nucleus receives input from:
The interposed nucleus shows significant degeneration in MSA-C (cerebellar variant):
The interposed nucleus is a primary target in many SCAs:
Key differentially expressed genes from Allen Brain Atlas:
The study of Interposed Nucleus (Interposed Cerebellar Nucleus) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
SCA pathogenesis: Matilla-Dueñas A. Molecular pathogenesis of spinocerebellar ataxias. 2014. ↩︎
Cerebellar DBS: Cooper SE. Deep brain stimulation for cerebellar disorders. 2008. ↩︎
Interposed nucleus in MSA: Gilman S. Neuropathology of MSA. 2003. ↩︎
Ataxia therapeutics: Klockgether T. Pharmacological treatment of cerebellar ataxia. 2020. ↩︎
Purkinje-interposed circuitry: De Zeeuw CI. Cerebellar microcircuitry. 2011. ↩︎
Transscriptomic profiling: Kebschull JM. Cerebellar nuclei neuron types. 2020. ↩︎
Gene therapy for ataxia: Stricker S. AAV gene therapy for cerebellar ataxia. 2019. ↩︎